Procept BioRobotics Corp (NASDAQ: PRCT) kicked off on Tuesday, down -8.25% from the previous trading day, before settling in for the closing price of $76.02. Over the past 52 weeks, PRCT has traded in a range of $44.02-$103.81.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 142.74% over the past five years. While this was happening, its average annual earnings per share was recorded 22.27%. With a float of $51.55 million, this company’s outstanding shares have now reached $52.15 million.
Let’s look at the performance matrix of the company that is accounted for 626 employees. In terms of profitability, gross margin is 56.09%, operating margin of -53.27%, and the pretax margin is -50.07%.
Procept BioRobotics Corp (PRCT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Procept BioRobotics Corp is 5.23%, while institutional ownership is 85.72%. The most recent insider transaction that took place on Dec 04 ’24, was worth 2,568,844. In this transaction President, CEO of this company sold 26,423 shares at a rate of $97.22, taking the stock ownership to the 152,762 shares. Before that another transaction happened on Dec 04 ’24, when Company’s EVP, CLO, CORP. SEC. sold 28,092 for $97.13, making the entire transaction worth $2,728,574. This insider now owns 52,472 shares in total.
Procept BioRobotics Corp (PRCT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.27% per share during the next fiscal year.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
Take a look at Procept BioRobotics Corp’s (PRCT) current performance indicators. Last quarter, stock had a quick ratio of 5.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.95, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.30 in one year’s time.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Procept BioRobotics Corp (NASDAQ: PRCT) saw its 5-day average volume 1.39 million, a positive change from its year-to-date volume of 0.92 million. As of the previous 9 days, the stock’s Stochastic %D was 3.36%. Additionally, its Average True Range was 4.36.
During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 8.61%, which indicates a significant increase from 6.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.28% in the past 14 days, which was lower than the 63.52% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $88.83, while its 200-day Moving Average is $73.03. Nevertheless, the first resistance level for the watch stands at $74.98 in the near term. At $80.20, the stock is likely to face the second major resistance level. The third major resistance level sits at $83.46. If the price goes on to break the first support level at $66.50, it is likely to go to the next support level at $63.24. Assuming the price breaks the second support level, the third support level stands at $58.02.
Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats
The company with the Market Capitalisation of 3.79 billion has total of 52,183K Shares Outstanding. Its annual sales at the moment are 136,190 K in contrast with the sum of -105,900 K annual income. Company’s last quarter sales were recorded 58,370 K and last quarter income was -20,970 K.
